Compare Stocks: PHUN, DOMO, RDCM, and ZSQR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DOMO Domo	$3.88 +2.4%	$3.66	$1.84 ▼ $18.49	$171.12M	1.76	935,900 shs	2.55 million shs
PHUN Phunware	$2.08 -0.5%	$2.11	$1.56 ▼ $3.13	$42.67M	2.61	81,644 shs	100,633 shs
RDCM Radcom	$10.03	$11.86	$9.40 ▼ $16.74	$167.89M	0.74	148,765 shs	96,977 shs
ZSQR Coeptis Therapeutics	$2.95 -3.0%	$5.48	$2.81 ▼ $21.41	$161.12M	-0.25	328,832 shs	265,725 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DOMO Domo	+2.71%	-3.07%	-1.30%	+11.14%	-73.99%
PHUN Phunware	+0.97%	-0.95%	-4.13%	+6.09%	-15.73%
RDCM Radcom	+0.60%	-3.65%	-2.53%	-18.59%	-25.32%
ZSQR Coeptis Therapeutics	-0.33%	-28.13%	-29.30%	-69.96%	-76.31%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DOMO Domo	$3.88 +2.4%	$3.66	$1.84 ▼ $18.49	$171.12M	1.76	935,900 shs	2.55 million shs
PHUN Phunware	$2.08 -0.5%	$2.11	$1.56 ▼ $3.13	$42.67M	2.61	81,644 shs	100,633 shs
RDCM Radcom	$10.03	$11.86	$9.40 ▼ $16.74	$167.89M	0.74	148,765 shs	96,977 shs
ZSQR Coeptis Therapeutics	$2.95 -3.0%	$5.48	$2.81 ▼ $21.41	$161.12M	-0.25	328,832 shs	265,725 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DOMO Domo	+2.71%	-3.07%	-1.30%	+11.14%	-73.99%
PHUN Phunware	+0.97%	-0.95%	-4.13%	+6.09%	-15.73%
RDCM Radcom	+0.60%	-3.65%	-2.53%	-18.59%	-25.32%
ZSQR Coeptis Therapeutics	-0.33%	-28.13%	-29.30%	-69.96%	-76.31%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DOMO Domo	1.67	Reduce	$3.95	1.91% Upside
PHUN Phunware	1.50	Reduce	$2.00	-3.85% Downside
RDCM Radcom	2.00	Hold	$14.00	39.58% Upside
ZSQR Coeptis Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest PHUN, DOMO, RDCM, and ZSQR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	DOMO Domo	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Underperform
8/17/2026	DOMO Domo	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Underperform
8/17/2026	DOMO Domo	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Underperform	$2.25
8/14/2026	ZSQR Coeptis Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E-)
8/12/2026	RDCM Radcom	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/12/2026	RDCM Radcom	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/12/2026	RDCM Radcom	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$18.00 ➝ $14.00
7/23/2026	DOMO Domo	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$4.84
7/23/2026	DOMO Domo	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Hold	$4.84
7/23/2026	DOMO Domo	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$5.00
7/23/2026	DOMO Domo	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$7.00 ➝ $5.00

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DOMO Domo	$318.86M	0.55	N/A	N/A	($4.75) per share	-0.82
PHUN Phunware	$2.55M	16.69	N/A	N/A	$4.33 per share	0.48
RDCM Radcom	$71.49M	2.35	$0.78 per share	12.81	$7.02 per share	1.43
ZSQR Coeptis Therapeutics	$1.36M	114.96	N/A	N/A	$2.50 per share	1.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DOMO Domo	-$59.34M	-$1.33	N/A	N/A	N/A	-17.43%	N/A	-25.99%	N/A
PHUN Phunware	-$11.40M	-$0.65	N/A	N/A	N/A	-471.72%	-13.79%	-12.37%	11/5/2026 (Estimated)
RDCM Radcom	$11.99M	$0.42	23.88	501.50	N/A	10.47%	6.51%	5.17%	11/11/2026 (Estimated)
ZSQR Coeptis Therapeutics	-$11.92M	-$1.63	N/A	N/A	N/A	-773.72%	-49.45%	-46.88%	N/A

Latest PHUN, DOMO, RDCM, and ZSQR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	ZSQR Coeptis Therapeutics	N/A	-$0.28	N/A	-$0.28	N/A	$1.58 million
8/12/2026	Q2 2026	RDCM Radcom	$0.24	-$0.09	-$0.33	-$0.18	$15.57 million	$11.76 million
8/6/2026	Q2 2026	PHUN Phunware	-$0.14	-$0.26	-$0.12	-$0.26	$0.80 million	$0.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DOMO Domo	N/A	N/A	N/A	N/A	N/A
PHUN Phunware	N/A	N/A	N/A	N/A	N/A
RDCM Radcom	N/A	N/A	N/A	N/A	N/A
ZSQR Coeptis Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DOMO Domo	N/A	0.31	0.31
PHUN Phunware	N/A	19.84	19.84
RDCM Radcom	N/A	6.20	6.17
ZSQR Coeptis Therapeutics	N/A	7.66	7.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DOMO Domo	76.64%
PHUN Phunware	7.57%
RDCM Radcom	48.32%
ZSQR Coeptis Therapeutics	13.88%

Insider Ownership

Company	Insider Ownership
DOMO Domo	13.25%
PHUN Phunware	0.20%
RDCM Radcom	69.00%
ZSQR Coeptis Therapeutics	24.25%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DOMO Domo	920	45.15 million	39.17 million	Optionable
PHUN Phunware	120	20.46 million	20.42 million	Optionable
RDCM Radcom	280	16.74 million	5.19 million	Not Optionable
ZSQR Coeptis Therapeutics	2	53.00 million	40.15 million	Not Optionable

PHUN, DOMO, RDCM, and ZSQR Headlines

Recent News About These Companies

Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.

August 14, 2026 | prnewswire.com

Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus

August 3, 2026 | prnewswire.com

Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement

July 17, 2026 | prnewswire.com

Z Squared Inc. Provides Capital Structure Update

July 15, 2026 | prnewswire.com

Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer

June 30, 2026 | prnewswire.com

Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy

June 29, 2026 | prnewswire.com

Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®

June 29, 2026 | prnewswire.com

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power

June 25, 2026 | prnewswire.com

Z Squared to Participate in Maxim Group's AI Data Center Summit

June 9, 2026 | prnewswire.com

Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout

June 4, 2026 | prnewswire.com

Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

May 27, 2026 | prnewswire.com

Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power

May 26, 2026 | globenewswire.com

Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads

May 19, 2026 | prnewswire.com

Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board

May 4, 2026 | prnewswire.com

Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW

April 29, 2026 | prnewswire.com

Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market

April 28, 2026 | prnewswire.com

Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application

April 27, 2026 | finanznachrichten.de

Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution

April 27, 2026 | tmcnet.com

Coeptis Therapeutics Receives Shareholder Approval Towards Z Squared Merger

April 27, 2026 | finanznachrichten.de

Z Squared Inc.: Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market

April 25, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, DOMO, RDCM, and ZSQR Company Descriptions

Domo NASDAQ:DOMO

$3.88 +0.09 (+2.37%)

As of 04:00 PM Eastern

Domo, Inc., together with its subsidiaries, operates a cloud-based business intelligence platform in North America, Western Europe, Canada, Australia, and Japan. Its platform digitally connects from the chief executive officer to the frontline employee with the various people, data, and systems in an organization, as well as giving them access to real-time data and insights, and allowing them to manage business via various browsers and visualization engines accessible across laptops, TV screens, monitors, tablets, and smartphones. The company was formerly known as Domo Technologies, Inc. and changed its name to Domo, Inc. in December 2011. Domo, Inc. was incorporated in 2010 and is headquartered in American Fork, Utah.

Phunware NASDAQ:PHUN

$2.08 -0.01 (-0.48%)

As of 04:00 PM Eastern

Phunware, Inc., together with its subsidiaries, provides integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include mobile software and application transaction solutions comprise integration of software development kit (SDK) licenses, which consists of analytics that offers data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging, which enables brands to send messages; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services, such as mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It is also involved in the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; and provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications, as well as application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization. Phunware, Inc. was founded in 2009 and is headquartered in Austin, Texas.

Radcom NASDAQ:RDCM

$10.03 0.00 (0.00%)

As of 04:00 PM Eastern

RADCOM Ltd. provides 5G ready cloud-native, network intelligence, and service assurance solutions for telecom operators or communication service providers (CSPs). It offers RADCOM ACE, including RADCOM Service Assurance, a cloud-native, 5G-ready, and virtualized service assurance solutions, which allows telecom operators to gain end-to-end network visibility and customer experience insights across all networks; RADCOM Network Visibility, a cloud-native network packet broker and filtering solution that allows CSPs to manage network traffic at scale across multiple cloud environments, and control the visibility layer to perform analysis of select datasets; and RADCOM Network Insights, a business intelligence solution that offers insights for multiple use cases enabled by data captured and correlated through RADCOM Network Visibility and RADCOM Service Assurance. The company also provides solutions for mobile and fixed networks, such as 5G, long term evolution (LTE), voice over LTE, voice over Wifi, IP multimedia subsystem, voice over IP, and universal mobile telecommunication service. It sells its products directly to customers through executives and sales representatives, as well as through a network of distributors and resellers in North America, Asia Pacific, Latin America, Europe, the Middle East, Africa, and Israel. The company was formerly known as Big Blue Catalogue Ltd. and changed its name to RADCOM Ltd. in 1989. RADCOM Ltd. was incorporated in 1985 and is headquartered in Tel Aviv, Israel.

Coeptis Therapeutics NASDAQ:ZSQR

$2.95 -0.09 (-2.96%)

As of 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHUN, DOMO, RDCM, and ZSQR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHUN, DOMO, RDCM, and ZSQR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHUN, DOMO, RDCM, and ZSQR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, DOMO, RDCM, and ZSQR Company Descriptions

Domo NASDAQ:DOMO

Phunware NASDAQ:PHUN

Radcom NASDAQ:RDCM

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHUN, DOMO, RDCM, and ZSQR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHUN, DOMO, RDCM, and ZSQR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHUN, DOMO, RDCM, and ZSQR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, DOMO, RDCM, and ZSQR Company Descriptions

Domo NASDAQ:DOMO

Phunware NASDAQ:PHUN

Radcom NASDAQ:RDCM

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools